
The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.

Kennedy Ferruggia is an assistant editor at Pharmacy Times®. She graduated from The College of New Jersey in 2023 in journalism and marketing. Prior to this position, she worked as a pharmacy associate for community pharmacies.

The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.

RSV could interact with nerve cells, causing nerve damage and possible entry to the spinal cord.

The 10-year cumulative incidence rate was equally high between both cohorts of smoking and nonsmoking individuals.

Individuals with ischemic stroke that resided in areas with an indoor radon concentration greater than 4 pCi/L had an increased risk of developing clonal hematopoiesis of indeterminate potential.

The report allows management to provide guaranteed assessments throughout the screenings that could aid early detection, diagnosis, and lung cancer treatment.

If vaccination coverage was increased by 100%, outpatient care could be reduced by 81.2%, hospitalizations by 91.7%, and deaths by 91.3%.

The prospective observational study assessed a 2-year increasing lung cancer diagnosis risk, lung cancer characteristics, and the overall survival between LNP and LDCT screening.

The study highlights the ongoing need for health care providers to recommend respiratory illness vaccinations to increase protection among nursing home residents during the peak season of infection.

Families that reported a lower income before the pandemic were more likely to experience hardships if headed by an adult with COVID-19 illness.

Overtime, children can outgrow food allergies, like milk and eggs—however, children with private insurance are more likely to outgrow allergies than those with public insurance.

The results found that INT301 met both its primary and secondary endpoints and could be a safe and effective option for individuals that experience food allergies.

Language gaps resulted in barriers and underdiagnosing in children with common allergies, limiting support for these patients and their families.

The antibody response among those that interrupted treatment was doubled at 4 weeks and 1.5 times greater at 26 weeks.

The most recent advances included an approved vaccine that could immunize both the elderly and pregnant women, along with the release of nirsevimab.

Older individuals and individuals that experienced severe COVID-19 are at high risk of increased cardiac disturbances.

The researchers emphasized that individuals must advocate for new policies that could aid regulation of harmful information being shared through social media platforms.

The update also removed the maximally tolerated qualifier for statin use and the statement that said morbidity and mortality was not yet determined.

Out of the 600 infants, 169 were born prematurely, 487 did not have underlying medical conditions, and 143 had to receive invasive mechanical ventilation.

The results found that the M2e nanoparticle injection could efficiently protect individuals from influenza A viruses.

Immune cells in lung cancer are connected to allergic conditions found in eczema and asthma.

Fractional COVID-19 dosing resulted in fewer adverse effects and costs while producing similar immune responses compared to a full dose vaccine.

The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.

The approval marks isavuconazonium sulfate as the only granted azole antifungal therapy for pediatric patients with invasive aspergillosia and invasive mucormycotic who are as young as age 1.

The approval marks levothyroxine sodium as the only FDA-granted LT4 therapy that does not have a labeled interaction with PPIs and can be taken 15 minutes prior to eating breakfast.

Fewer individuals have received the flu shot this season, compared to previous years.

There is a great need to protect families and children that are commercially insured following the COVID-19 pandemic.

Individuals treated with remibrutinib demonstrated symptom control improvement in week 2 of the trial

Peanut sublingual immunotherapy offers a practical treatment option for peanut-allergic toddlers, reducing symptoms in 80% of children.

Pediatric individuals that are higher risk for APS must be followed to better understand affects

The growth chart could be a fast and accessible resource to indicate lean muscle mass in children.